Format

Send to

Choose Destination
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12432-7. Epub 2002 Aug 30.

Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.

Author information

1
Neuroscience Program, International School for Advanced Studies (SISSA), Via Beirut 2-4, 34014 Trieste, Italy.

Abstract

Phenotypic knockout of nerve growth factor (NGF) activity in transgenic anti-NGF mice (AD11 mice) results in a progressive neurodegenerative phenotype resembling Alzheimer's disease. In this article, we examine whether and how the progressive neurodegenerative phenotype of AD11 mice could be prevented or ameliorated by pharmacological treatments with NGF or the cholinergic agonist galantamine, at a relatively early phase of Alzheimer's disease-like neurodegeneration. We demonstrate that the neurodegeneration induced by the expression of anti-NGF antibodies in AD11 mice can be largely reversed by NGF delivery through an olfactory route.

PMID:
12205295
PMCID:
PMC129462
DOI:
10.1073/pnas.192442999
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center